First Mercantile Trust’s Kura Oncology KURA Stock Holding History

First Mercantile Trust’s Portfolio KURA Stock Details KURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-3,484	Closed	-$73K	–	864
2021 Q2	$73K	Sell	3,484 -316	-8%	-$7.84K	0.01%	753
2021 Q1	$107K	Buy	3,800 +330	+10%	+$10.4K	0.01%	659
2020 Q4	$113K	Buy	3,470 +521	+18%	+$18.3K	0.01%	650
2020 Q3	$111K	Buy	+2,949	New	+$65.1K	0.01%	644

Other funds holding KURA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

First Mercantile Trust's KURA Position: Q3 2021 in Review

First Mercantile Trust sold out of Kura Oncology (KURA) in Q3 2021, closing a stake of 3,484 shares — an estimated $73K sold.

First Mercantile Trust first reported a position in KURA in Q3 2020 and held it in 4 quarters. The position peaked at $113K in Q4 2020. 152 funds tracked by Wall St. Rank hold KURA as of Q3 2021.

First Mercantile Trust reported no remaining Kura Oncology position as of Q3 2021 after selling out during the quarter.
First Mercantile Trust sold 3,484 Kura Oncology shares in Q3 2021, an estimated $73K.
First Mercantile Trust first reported a position in Kura Oncology in Q3 2020 and held it in 4 quarters.
First Mercantile Trust's Kura Oncology position peaked at $113K in Q4 2020.
152 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2021.

Based on First Mercantile Trust's 13F filing for Q3 2021, filed 24 Nov 2021.